Genetic Modifiers of Osteogenic Sarcoma: Study Publications

• Fitzhugh CD, Wise B, Baird K, Tsokos M, Helman L, Mackall C, Savage SA, Warren KE. Secondary supratentorial primitive neuroectodermal tumor following treatment of childhood osteosarcoma. Pediatr Blood Cancer 2009 May 11.
• Mirabello L, Troisi RJ, Savage SA. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer 2009 Jul 1;125(1):229-34.
• Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer 2009 Apr 1;115(7):1531-43.
• Savage SA, Woodson K, Walk E, Modi W, Liao J, Douglass C, Hoover RN, Chanock SJ; National Osteosarcoma Etiology Study Group. Analysis of genes critical for growth regulation identifies Insulin-like Growth Factor 2 Receptor variations with possible functional significance as risk factors for osteosarcoma. Cancer Epidemiol Biomarkers Prev 2007 Aug;16(8):1667-74.
• Savage SA, Burdett L, Troisi R, Douglass C, Hoover RN, Chanock SJ; National Osteosarcoma Etiology study group. Germ-line genetic variation of TP53 in osteosarcoma. Pediatr Blood Cancer 2007 Jul;49(1):28-33.
• Troisi R, Masters MN, Joshipura K, Douglass C, Cole BF, Hoover RN. Perinatal factors, growth and development, and osteosarcoma risk. Br J Cancer 2006 Dec 4;95(11):1603-7.
• Savage SA, Stewart BJ, Liao JS, Helman LJ, Chanock SJ. Telomere stability genes are not mutated in osteosarcoma cell lines. Cancer Genet Cytogenet 2005 Jul 1;160(1):79-81.